HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,166 | -20.0% | 53,301 | -28.9% | 0.01% | -16.7% |
| Q2 2023 | $7,709 | +131.6% | 74,963 | +145.7% | 0.01% | +100.0% |
| Q1 2023 | $3,329 | -24.6% | 30,506 | -21.4% | 0.00% | -40.0% |
| Q4 2022 | $4,414 | -99.8% | 38,793 | +6.9% | 0.01% | +66.7% |
| Q2 2022 | $2,893,000 | +22.4% | 36,280 | +65.4% | 0.00% | +50.0% |
| Q4 2021 | $2,363,000 | +30.4% | 21,935 | +16.9% | 0.00% | 0.0% |
| Q3 2021 | $1,812,000 | -1.7% | 18,769 | -4.7% | 0.00% | 0.0% |
| Q2 2021 | $1,844,000 | – | 19,699 | -59.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 48,682 | -15.2% | 0.00% | -100.0% |
| Q4 2020 | $4,197,000 | +249.8% | 57,376 | +271.3% | 0.01% | +150.0% |
| Q3 2020 | $1,200,000 | +2005.3% | 15,451 | +633.3% | 0.00% | – |
| Q3 2019 | $57,000 | -45.7% | 2,107 | -51.8% | 0.00% | – |
| Q2 2019 | $105,000 | – | 4,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |